全文获取类型
收费全文 | 6428篇 |
免费 | 427篇 |
国内免费 | 178篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 174篇 |
妇产科学 | 91篇 |
基础医学 | 397篇 |
口腔科学 | 99篇 |
临床医学 | 742篇 |
内科学 | 725篇 |
皮肤病学 | 75篇 |
神经病学 | 306篇 |
特种医学 | 715篇 |
外科学 | 821篇 |
综合类 | 1056篇 |
现状与发展 | 2篇 |
一般理论 | 2篇 |
预防医学 | 698篇 |
眼科学 | 28篇 |
药学 | 457篇 |
2篇 | |
中国医学 | 336篇 |
肿瘤学 | 271篇 |
出版年
2023年 | 35篇 |
2022年 | 111篇 |
2021年 | 181篇 |
2020年 | 120篇 |
2019年 | 98篇 |
2018年 | 101篇 |
2017年 | 97篇 |
2016年 | 92篇 |
2015年 | 152篇 |
2014年 | 228篇 |
2013年 | 260篇 |
2012年 | 423篇 |
2011年 | 468篇 |
2010年 | 429篇 |
2009年 | 393篇 |
2008年 | 408篇 |
2007年 | 409篇 |
2006年 | 396篇 |
2005年 | 318篇 |
2004年 | 251篇 |
2003年 | 193篇 |
2002年 | 163篇 |
2001年 | 163篇 |
2000年 | 168篇 |
1999年 | 103篇 |
1998年 | 49篇 |
1997年 | 40篇 |
1996年 | 48篇 |
1995年 | 34篇 |
1994年 | 40篇 |
1993年 | 35篇 |
1992年 | 91篇 |
1991年 | 67篇 |
1990年 | 78篇 |
1989年 | 77篇 |
1988年 | 81篇 |
1987年 | 80篇 |
1986年 | 79篇 |
1985年 | 68篇 |
1984年 | 56篇 |
1983年 | 35篇 |
1982年 | 21篇 |
1981年 | 21篇 |
1980年 | 20篇 |
1979年 | 26篇 |
1978年 | 41篇 |
1977年 | 31篇 |
1976年 | 23篇 |
1975年 | 28篇 |
1974年 | 22篇 |
排序方式: 共有7033条查询结果,搜索用时 31 毫秒
2.
目的:应用99mTc-DTPA肾动脉显像评价Stanford不同分型主动脉夹层患者术后左、右侧肾功能及总体肾功能受损程度,帮助临床制定进一步的治疗方案,改善患者预后。方法:回顾性分析2018年3月8日至2019年7月19日,在本院核医学科行99mTc-DTPA肾动态显像的主动脉夹层术后患者48例,评价患者双肾血流灌注、总肾小球滤过率(GFR)和分肾的GFR,比较Stanford主动脉夹层A型(简称A型)患者和主动脉夹层B型(简称B型)患者之间总肾功能及分肾功能,血肌酐、血尿素氮及血尿酸水平的差异。结果:B型患者术后总GFR低于A型患者(67.5 vs.80.6 m L/min,P<0.05),其中以左肾功能受损为著(30.9 vs.40.3 m L/min,P<0.05),差异有统计学意义。结论:肾动态显像对主动脉夹层术后患者早期评价肾功能有重要价值。主动脉夹层B型患者GFR较A型减低,且左侧肾GFR减低更明显,临床可以早期采取干预措施,改善主动脉夹层患者预后。 相似文献
3.
痤疮可辨为阴、阳两证。阳疮者,缘患者劳汗被寒、玄府闭合,汗脂凝聚日久不得外排,蕴热搏结气血而生疮化腐,疮症为热为痛,此为易治;阴疮者,由阳疮转化而来,缘患者外感寒风、内伤生冷,且医者又重用寒凉、失于托透,以至气血冰凝,久不溃脓或溃脓难出,此为难治。根据难治性痤疮临床表现,其多类属于阴疮,以阳虚表郁、邪闭毛窍为致病之关键,其中表郁毛窍、邪闭肌腠为病之标,阳虚阴凝为病之本。治疗当以温阳透发、祛邪外达为法。以麻黄附子细辛汤温阳化阴滞、发阳透毒治其本,待阴邪发越,即用火针强开门户、消疮排脓治其标。标本兼治、针药结合的方法治疗难治性痤疮在临床中能够安全有效地消除痤疮、改善皮损、降低复发率。 相似文献
5.
GIUSEPPE BORIANI MAURO BIFFI MAURIZIO RUSSO† MAURIZIO LUNATI‡ GIANLUCA BOTTO¶ ALESSANDRO PROCLEMER§ GIUSEPPE VERGARA WERNER RAHUE†† CRISTIAN MARTIGNANI RENATO RICCI† MASSIMO SANTINI† On Behalf of the SEARCH MI Registry Italian Investigators 《Pacing and clinical electrophysiology : PACE》2006,29(S2):S29-S34
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
6.
目的 探讨P16、P15、P14基因5'CpG岛在膀胱移行细胞癌中甲基化状态及其临床意义。方法 应用甲基化特异性PCR(methylation—specific PCR,MSP)方法检测40例膀胱移行细胞癌P16、P15、P14基因甲基化程度,χ^2检验分析其甲基化程度与膀胱癌病理分级分期间关系。结果 膀胱移行细胞癌P16、P15、P14 5'CpG岛甲基化扩增阳性化率分别为27.5%、17.5%、35%,而正常膀胱组织中均未检测到三种基因5'CpG岛甲基化。P16、P14基因甲基化与膀胱癌病理分级分期有显著性差异(P〈0.05),P15基因则没有显著性差异(P〉0.05)。结论 P16、P15、P14基因在膀胱癌组织中的甲基化率较高,三种抑癌基因5'CpG岛异常高甲基化,在膀胱癌的发生、发展中具有重要作用。 相似文献
7.
听觉诱发电位指数、脑电双频指数对异丙酚麻醉下患者术中体动反应的预测 总被引:2,自引:0,他引:2
目的评价听觉诱发电位指数(AAI)、脑电双频指数(BIS)预测异丙酚麻醉下患者术中体动反应的可能性。方法择期行妇科手术全麻患者28例,ASAⅠ或Ⅱ级,年龄24-62岁,体重46- 71 kg,术前2 h口服咪达唑仑10 mg,入室后以血浆靶浓度3.5μg/ml靶控输注异丙酚、静脉注射芬太尼2μg/kg及维库溴铵0.1 mg/kg麻醉诱导,气管插管后,调整异丙酚血浆靶浓度维持BIS 40-60。切皮后不再追加肌松剂,观察患者术中头面部及四肢的体动反应,记录体动反应发生前、后2min内BIS、AAI的最大值(BISmax、AAImax)及此时段内BIS>75、AAI>40的次数及出现时间。记录术中当BIS>75、AAI>40时前、后2 min内有无体动反应发生及发生时间。结果12例出现体动反应,体动前、后2 min内BISmax为63±16(4例BIS>75,33.3%),AAImax为48±11(12例AAI>40,100%)。麻醉维持过程中,出现14次BIS>75,并发体动反应4次(28.5%),BIS反应时间较体动时间滞后(84±19)s;出现AAI>40者28次,并发体动者12次(42.8%),AAI反应时间较体动时间滞后(13±3)s。结论异丙酚麻醉下BIS、AAI反应时间较体动发生时间滞后,不能预测术中体动反应的发生。 相似文献
8.
R B Resnick E Resnick M Galanter 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(4):531-538
1. A 26-32 month follow-up of 16 heroin-dependent subjects who entered a pilot trial of treatment with buprenorphine (a mixed agonist/antagonist) suggests that positive response to treatment may identify a subgroup of untreated addicts whose levels of psychosocial functioning are intermediate between those for whom methadone (a pure agonist) or naltrexone (a pure antagonist) would be indicated. 2. Buprenorphine's pharmacologic profile provides a missing link in available modalities for opiate dependence treatment, making it acceptable for many addicts who will not accept methadone maintenance treatment, join a residential therapeutic community, or be successful on naltrexone treatment. 3. Eight of the 16 ss were abstinent from heroin while receiving 0.6-3.9 mg/day buprenorphine and counseling. Responders (mean age 34 yrs) had been heroin dependent for a mean of 9.5 years (range 6-17 yrs), all were self-supporting, 4 lived with a non-addicted spouse, 5 had no prior treatment for addiction and 3 had prior naltrexone treatment, but had discontinued it and relapsed. Non-responders (mean age 30 yrs) had been heroin dependent for a mean of 7.4 yrs (range 2-19 yrs), 7 had no regular employment, all were single and 7 had no prior treatment for addiction. 4. Levels of psychosocial functioning (work, home, leisure) and global assessments of functioning were significantly higher for buprenorphine responders than non-responders (p less than .001 and p less than .01 respectively). 5. A new formulation of buprenorphine needs to be developed for addiction treatment, ideally consisting of 0.5 mg and 2.0 mg sublingual tablets. 相似文献
9.
S Kursunoglu P Kaplan D Resnick D J Sartoris 《Journal of oral and maxillofacial surgery》1986,44(4):257-259
Ten temporomandibular joints, obtained from three asymptomatic patients and two cadavers, were examined by three-dimensional computed tomography. The osseous components of the condylar process of the mandible and the glenoid fossa of the temporal bone were well visualized. The meniscus was visualized in both the closed- and the open-mouthed positions. Advantages and disadvantages of the technique are discussed. 相似文献
10.
P M Schulz S C Schulz S C Goldberg P Ettigi R J Resnick R O Friedel 《The Journal of nervous and mental disease》1986,174(8):457-463
Relatives of 22 schizotypal probands were evaluated for lifetime psychiatric diagnoses. Forty-four (N = 44) of the 97 available relatives were interviewed directly using the Diagnostic Interview Schedule. The rates of psychiatric diagnoses were compared with those of sixty-six (N = 66) of 140 relatives of 30 depressed patients. Family history of mental illness was ascertained by the informant method on the remainder of relatives of both proband groups. The rate of depression found in the relatives of schizotypal patients was 52% in those directly interviewed and 25.7% when informants' reports on unavailable relatives are pooled with direct interview data. These rates were not significantly higher than those found for the relatives of depressed probands (34.8% by direct interview and 21% including reports from informants). The high rates of depression in the relatives of schizotypal probands may indicate that schizotypal personality is associated with affective disorder and not only with schizophrenia. However, the high rates may be due to the presence of depressive character traits in relatives, which inflate the rates of dysthymic disorder and other chronic depressive disorders in the relatives of borderline patients. 相似文献